MAINZ BIOMED NV (QUCY) Stock Balance Sheet
NASDAQ:QUCY • NL0015000LC2
Current stock price
0.4569 USD
-0.04 (-8.95%)
At close:
0.4231 USD
-0.03 (-7.4%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 889.10K | 6.24M | 7.07M | 17.14M | 8.73M | |||
| Receivables | 110.90K | 213.80K | 354.50K | 260.00K | 110.00K | |||
| Inventories | 216.90K | 372.90K | 613.60K | 180.00K | N/A | |||
| Other Current Assets | 624.80K | 1.02M | 940.80K | 800.00K | 770.00K | |||
| Total Current Assets | 1.84M | 7.84M | 8.98M | 18.38M | 9.61M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.37M | 2.38M | 3.03M | 1.84M | 430.00K | |||
| Intangibles | 1.11M | 3.02M | 3.39M | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | 100.00 | 20.00K | N/A | |||
| Total Non-Current Assets | 3.49M | 5.39M | 6.43M | 1.86M | 430.00K | |||
| TOTAL ASSETS | 5.33M | 13.24M | 15.41M | 20.24M | 10.04M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.14M | 0.00 | 0.00 | 0.00 | 120.00K | |||
| Current Portion Of LT Debt. | 438.40K | 1.37M | 5.22M | 360.00K | 130.00K | |||
| Accrued Expenses | 525.30K | 1.04M | 857.90K | 1.58M | 270.00K | |||
| Accounts Payable | 425.10K | 1.81M | 6.11M | 1.33M | 830.00K | |||
| Other Current Liabilities | 1.16M | 1.72M | 527.70K | 970.00K | 0.00 | |||
| Total Current Liabilities | 3.69M | 5.95M | 9.24M | 4.24M | 1.35M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 992.50K | 866.00K | 1.17M | 960.00K | 390.00K | |||
| Other Non-Current Liabilities | 0.00 | 376.10K | 1.76M | 940.00K | 1.94M | |||
| Total Non-Current Liabilities | 992.50K | 1.24M | 2.92M | 1.90M | 2.33M | |||
| TOTAL LIABILITIES | 4.69M | 7.19M | 12.16M | 6.14M | 3.68M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -104.90M | -63.38M | -48.04M | -24.95M | -6.91M | |||
| Additional Paid In Capital | 106.05M | 69.06M | 51.51M | 38.83M | 13.13M | |||
| Common Shares | 107.80K | 922.10K | 235.80K | 160.00K | 140.00K | |||
| Other Shareholders' Equity | -617.70K | -556.90K | -452.30K | 50.00K | 0.00 | |||
| Shares Outstanding | 9.78M | 2.32M | 529.20K | 365.70K | 349.00K | |||
| Tangible Book Value per Share | -0.05 | 1.31 | -0.27 | 0.96 | 0.46 | |||
| Total Shareholders' Equity | 641.60K | 6.05M | 3.25M | 14.10M | 6.36M | |||
| TOTAL LIABILITIES AND EQUITY | 5.33M | 13.24M | 15.41M | 20.24M | 10.04M | |||
| Statistics | ||||||||
| Debt/Equity | 3.32 | 0.14 | 0.36 | 0.07 | 0.08 | |||
| Current Ratio | 0.50 | 1.32 | 0.97 | 4.33 | 7.12 | |||
| Return On Assets (ROA) | -304.29% | -163.55% | -170.65% | -130.39% | -116.43% | |||
| Return On Equity (ROE) | -2526.61% | -358.07% | -809.30% | -187.16% | -183.81% | |||
All data in USD , ROIC based on taxRate of 0.21